You are here: Home / Our people / Our people / Academic staff list / Dr Danqing Min 

Dr Danqing Min

Senior Research Fellow
Medicine, Central Clinical School

Telephone 8627 1706
Fax 8627 1604

Map

Research interests

Dr Min's principal research interests focus on understanding the molecular mechanisms of inflammation responses during the development of diabetic complications which investigating a): the role of monocyte/macrophage in diabetes and diabetic complications. b): the role of the matrix metalloproteinases (MMPs)/ their tissue inhibitors (TIMPs) involved in the development of diabetic complications. c): the targeted gene therapy and combination therapy on control the development of diabetic complications.

Back to Top

Selected grants

2014

  • Characterization of effect of diabetes on the anti-inflammatory CD163+ monocytes: possible role in the development of diabetic nephropathy; Min D; Diabetes Australia Research Trust (DART)/Research Grants.
  • Circulating monocyte phenotype: Is it altered in association with the development of diabetic complications; McLennan S, Twigg S, Min D; Rebecca L Cooper Medical Research Foundation/Equipment Grant.

2011

  • Preventing Adverse Effects of Matrix Metalloproteinases in Diabetic Wound Healing; McLennan S, Twigg S, Min D, Yue D; National Health and Medical Research Council (NHMRC)/Project Grants.
Back to Top

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Min, D., Brooks, B., Wong, J., Aamidor, S., Seehoo, R., Sutanto, S., Harrisberg, B., Yue, D., Twigg, S., McLennan, S. (2016). Monocyte CD163 is altered in association with diabetic complications: possible protective role. Journal of Leukocyte Biology, 100(6), 1375-1383. [More Information]
  • Scott, C., Bonner, J., Min, D., Boughton, P., Stokes, R., Cha, K., Walters, S., Masolowski, K., Sierro, F., Grey, S., Twigg, S., McLennan, S., Gunton, J. (2014). Reduction of ARNT in myeloid cells causes immune suppression and delayed wound healing. American Journal of Physiology: Cell Physiology, 307(4), C349-C357. [More Information]
  • Min, D., Brooks, B., Wong, J., Salomon, R., Bao, W., Harrisberg, B., Twigg, S., Yue, D., McLennan, S. (2012). Alterations in Monocyte CD16 in Association with Diabetes Complications. Mediators of Inflammation, 2012, 1-10. [More Information]
  • Bao, W., Min, D., Twigg, S., Shackel, N., Warner, F., Yue, D., McLennan, S. (2010). Monocyte CD147 is induced by advanced glycation end products and high glucose concentration: possible role in diabetic complications. American Journal of Physiology: Cell Physiology, 299(5), C1212-C1219. [More Information]
  • Zheng, G., Lyons, J., Tan, T., Wang, Y., Hsu, T., Min, D., Succar, L., Rangan, G., Hu, M., Henderson, B., Alexander, S., Harris, D. (2009). Disruption of E-Cadherin by Matrix Metalloproteinase Directly Mediates Epithelial-Mesenchymal Transition Downstream of Transforming Growth Factor-{beta}1 in Renal Tubular Epithelial Cells. The American Journal of Pathology, 175(2), 580-591. [More Information]
  • Liu, Y., Min, D., Bolton, T., Nube, V., Twigg, S., Yue, D., McLennan, S. (2009). Increased Matrix Metalloproteinase-9 Predicts Poor Wound Healing in Diabetic Foot Ulcers. Diabetes Care, 32(1), 117-119. [More Information]
  • Min, D., Lyons, G., Bonner, J., Twigg, S., Yue, D., McLennan, S. (2009). Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy. American Journal of Physiology: Renal Physiology, 297(5), F1229-F1237. [More Information]
  • Wong, J., McLennan, S., Molyneaux, L., Min, D., Twigg, S., Yue, D. (2009). Mitochondrial DNA content in peripheral blood monocytes: relationship with age of diabetes onsetand diabetic complications. Diabetologia, 52, 1953-1961. [More Information]
  • McLennan, S., Min, D., Zaman, S. (2008). Matrix metalloproteinases: their role in poor wound healing in diabetes. Wound Practice & Research, 16, 116-120.
  • Min, D., Lyons, G., Jia, J., Lo, L., McLennan, S. (2006). 2-Methoxy-2,4-diphenyl-3(2H)-furanone-labeled gelatin zymography and reverse zymography: a rapid real-time method for quantification of matrix metalloproteinases-2 and -9 and tissue inhibitors of metalloproteinases. Electrophoresis, 27(2), 357-364. [More Information]
  • Underwood, C., Min, D., Lyons, G., Hambley, T. (2003). The interaction of metal ions and Marimastat with matrix metalloproteinase 9. Journal of Inorganic Biochemistry, 95(2-3), 165-170. [More Information]

2016

  • Min, D., Brooks, B., Wong, J., Aamidor, S., Seehoo, R., Sutanto, S., Harrisberg, B., Yue, D., Twigg, S., McLennan, S. (2016). Monocyte CD163 is altered in association with diabetic complications: possible protective role. Journal of Leukocyte Biology, 100(6), 1375-1383. [More Information]

2014

  • Scott, C., Bonner, J., Min, D., Boughton, P., Stokes, R., Cha, K., Walters, S., Masolowski, K., Sierro, F., Grey, S., Twigg, S., McLennan, S., Gunton, J. (2014). Reduction of ARNT in myeloid cells causes immune suppression and delayed wound healing. American Journal of Physiology: Cell Physiology, 307(4), C349-C357. [More Information]

2012

  • Min, D., Brooks, B., Wong, J., Salomon, R., Bao, W., Harrisberg, B., Twigg, S., Yue, D., McLennan, S. (2012). Alterations in Monocyte CD16 in Association with Diabetes Complications. Mediators of Inflammation, 2012, 1-10. [More Information]

2010

  • Bao, W., Min, D., Twigg, S., Shackel, N., Warner, F., Yue, D., McLennan, S. (2010). Monocyte CD147 is induced by advanced glycation end products and high glucose concentration: possible role in diabetic complications. American Journal of Physiology: Cell Physiology, 299(5), C1212-C1219. [More Information]

2009

  • Zheng, G., Lyons, J., Tan, T., Wang, Y., Hsu, T., Min, D., Succar, L., Rangan, G., Hu, M., Henderson, B., Alexander, S., Harris, D. (2009). Disruption of E-Cadherin by Matrix Metalloproteinase Directly Mediates Epithelial-Mesenchymal Transition Downstream of Transforming Growth Factor-{beta}1 in Renal Tubular Epithelial Cells. The American Journal of Pathology, 175(2), 580-591. [More Information]
  • Liu, Y., Min, D., Bolton, T., Nube, V., Twigg, S., Yue, D., McLennan, S. (2009). Increased Matrix Metalloproteinase-9 Predicts Poor Wound Healing in Diabetic Foot Ulcers. Diabetes Care, 32(1), 117-119. [More Information]
  • Min, D., Lyons, G., Bonner, J., Twigg, S., Yue, D., McLennan, S. (2009). Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy. American Journal of Physiology: Renal Physiology, 297(5), F1229-F1237. [More Information]
  • Wong, J., McLennan, S., Molyneaux, L., Min, D., Twigg, S., Yue, D. (2009). Mitochondrial DNA content in peripheral blood monocytes: relationship with age of diabetes onsetand diabetic complications. Diabetologia, 52, 1953-1961. [More Information]

2008

  • McLennan, S., Min, D., Zaman, S. (2008). Matrix metalloproteinases: their role in poor wound healing in diabetes. Wound Practice & Research, 16, 116-120.

2006

  • Min, D., Lyons, G., Jia, J., Lo, L., McLennan, S. (2006). 2-Methoxy-2,4-diphenyl-3(2H)-furanone-labeled gelatin zymography and reverse zymography: a rapid real-time method for quantification of matrix metalloproteinases-2 and -9 and tissue inhibitors of metalloproteinases. Electrophoresis, 27(2), 357-364. [More Information]

2003

  • Underwood, C., Min, D., Lyons, G., Hambley, T. (2003). The interaction of metal ions and Marimastat with matrix metalloproteinase 9. Journal of Inorganic Biochemistry, 95(2-3), 165-170. [More Information]
Back to Top

To update your profile click here. For support on your academic profile contact .